Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class ASSE: 600276

Announcement on Obtaining Notice of Approval for Drug Clinical Trial

· Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Obtaining Notice of Approval for Drug Clinical Trial

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment